Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Muscle-specific overexpression of NCOATGK, splice variant of O-GlcNAcase, induces skeletal muscle atrophy.

Huang P, Ho SR, Wang K, Roessler BC, Zhang F, Hu Y, Bowe DB, Kudlow JE, Paterson AJ.

Am J Physiol Cell Physiol. 2011 Mar;300(3):C456-65. doi: 10.1152/ajpcell.00124.2010. Epub 2010 Dec 22.

2.

O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress.

Ho SR, Wang K, Whisenhunt TR, Huang P, Zhu X, Kudlow JE, Paterson AJ.

FEBS Lett. 2010 Jan 4;584(1):49-54. doi: 10.1016/j.febslet.2009.11.059.

3.

Increased O-GlcNAc causes disrupted lens fiber cell differentiation and cataracts.

Wang K, Ho SR, Mao W, Huang P, Zhang F, Schwiebert EM, Kudlow JE, Paterson AJ.

Biochem Biophys Res Commun. 2009 Sep 11;387(1):70-6. doi: 10.1016/j.bbrc.2009.06.132. Epub 2009 Jul 3.

4.

Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance.

Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ, Evans RM.

Nature. 2008 Feb 21;451(7181):964-9. doi: 10.1038/nature06668.

PMID:
18288188
5.

Metabolic control of proteasome function.

Zhang F, Paterson AJ, Huang P, Wang K, Kudlow JE.

Physiology (Bethesda). 2007 Dec;22:373-9. Review.

6.

Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6.

Zhang F, Hu Y, Huang P, Toleman CA, Paterson AJ, Kudlow JE.

J Biol Chem. 2007 Aug 3;282(31):22460-71. Epub 2007 Jun 12.

7.

Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid.

Manzari B, Kudlow JE, Fardin P, Merello E, Ottaviano C, Puppo M, Eva A, Varesio L.

Int J Immunopathol Pharmacol. 2007 Jan-Mar;20(1):47-58.

PMID:
17346427
8.

O-GlcNAc integrates the proteasome and transcriptome to regulate nuclear hormone receptors.

Bowe DB, Sadlonova A, Toleman CA, Novak Z, Hu Y, Huang P, Mukherjee S, Whitsett T, Frost AR, Paterson AJ, Kudlow JE.

Mol Cell Biol. 2006 Nov;26(22):8539-50. Epub 2006 Sep 11.

9.

Post-translational modification by O-GlcNAc: another way to change protein function.

Kudlow JE.

J Cell Biochem. 2006 Aug 1;98(5):1062-75.

PMID:
16598783
10.

Location and characterization of the O-GlcNAcase active site.

Toleman C, Paterson AJ, Kudlow JE.

Biochim Biophys Acta. 2006 May;1760(5):829-39. Epub 2006 Feb 20.

PMID:
16517082
11.

Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.

Whisenhunt TR, Yang X, Bowe DB, Paterson AJ, Van Tine BA, Kudlow JE.

Glycobiology. 2006 Jun;16(6):551-63. Epub 2006 Feb 27.

PMID:
16505006
12.

Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog.

Toleman C, Paterson AJ, Shin R, Kudlow JE.

Biochem Biophys Res Commun. 2006 Feb 10;340(2):526-34. Epub 2005 Dec 19.

PMID:
16376298
13.

The histone acetyltransferase NCOAT contains a zinc finger-like motif involved in substrate recognition.

Toleman CA, Paterson AJ, Kudlow JE.

J Biol Chem. 2006 Feb 17;281(7):3918-25. Epub 2005 Dec 15.

14.

Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine.

Roh M, Paterson AJ, Liu K, McAndrew J, Chin E, Kudlow JE.

Biochim Biophys Acta. 2005 Apr 15;1743(3):231-42. Epub 2004 Nov 23.

15.

Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia.

Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo-Ruppert SM, Ruppert JM.

Oncogene. 2005 Feb 24;24(9):1491-500.

16.

Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.

Toleman C, Paterson AJ, Whisenhunt TR, Kudlow JE.

J Biol Chem. 2004 Dec 17;279(51):53665-73. Epub 2004 Oct 12.

17.

Health-care charges generated by patients with diabetes.

Bell DS, Kudlow JE, Tidwell M.

Endocr Pract. 1998 Jul-Aug;4(4):237-9.

PMID:
15251738
18.

Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism.

Liu K, Paterson AJ, Zhang F, McAndrew J, Fukuchi K, Wyss JM, Peng L, Hu Y, Kudlow JE.

J Neurochem. 2004 May;89(4):1044-55.

19.

Phosphorylation of mouse glutamine-fructose-6-phosphate amidotransferase 2 (GFAT2) by cAMP-dependent protein kinase increases the enzyme activity.

Hu Y, Riesland L, Paterson AJ, Kudlow JE.

J Biol Chem. 2004 Jul 16;279(29):29988-93. Epub 2004 May 7.

20.

Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein.

Hafner M, Wenk J, Nenci A, Pasparakis M, Scharffetter-Kochanek K, Smyth N, Peters T, Kess D, Holtkötter O, Shephard P, Kudlow JE, Smola H, Haase I, Schippers A, Krieg T, Müller W.

Genesis. 2004 Apr;38(4):176-81.

PMID:
15083518
22.

O-GlcNAc modification is an endogenous inhibitor of the proteasome.

Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE.

Cell. 2003 Dec 12;115(6):715-25.

23.

The role of O-linked protein glycosylation in beta-cell dysfunction.

Konrad RJ, Kudlow JE.

Int J Mol Med. 2002 Nov;10(5):535-9. Review.

PMID:
12373287
24.

The O-GlcNAcase theory of diabetes: commentary on a candidate gene for diabetes.

Kudlow JE.

Mol Genet Metab. 2002 Sep-Oct;77(1-2):1-2. No abstract available.

PMID:
12359123
25.

Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion.

Liu K, Paterson AJ, Konrad RJ, Parlow AF, Jimi S, Roh M, Chin E Jr, Kudlow JE.

Mol Cell Endocrinol. 2002 Aug 30;194(1-2):135-46.

PMID:
12242036
27.

Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.

Konrad RJ, Zhang F, Hale JE, Knierman MD, Becker GW, Kudlow JE.

Biochem Biophys Res Commun. 2002 Apr 26;293(1):207-12.

PMID:
12054585
28.

Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase.

Konrad RJ, Tolar JF, Hale JE, Knierman MD, Becker GW, Kudlow JE.

Biochem Biophys Res Commun. 2001 Nov 16;288(5):1136-40.

PMID:
11700029
29.

O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.

Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6611-6. Epub 2001 May 22.

30.
31.
32.

In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells.

Gadi VK, Alexander SD, Kudlow JE, Allan P, Parker WB, Sorscher EJ.

Gene Ther. 2000 Oct;7(20):1738-43.

35.

Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1.

Su K, Yang X, Roos MD, Paterson AJ, Kudlow JE.

Biochem J. 2000 Jun 1;348 Pt 2:281-9.

36.
37.
38.

Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets.

Konrad RJ, Janowski KM, Kudlow JE.

Biochem Biophys Res Commun. 2000 Jan 7;267(1):26-32.

PMID:
10623569
40.

An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro.

Su K, Roos MD, Yang X, Han I, Paterson AJ, Kudlow JE.

J Biol Chem. 1999 May 21;274(21):15194-202.

42.

Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins.

Roos MD, Xie W, Su K, Clark JA, Yang X, Chin E, Paterson AJ, Kudlow JE.

Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):422-32.

PMID:
9756093
44.
45.
46.
47.

O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions.

Roos MD, Su K, Baker JR, Kudlow JE.

Mol Cell Biol. 1997 Nov;17(11):6472-80.

48.

MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.

Xie W, Su K, Wang D, Paterson AJ, Kudlow JE.

Anticancer Res. 1997 Jul-Aug;17(4A):2627-33.

PMID:
9252692
49.
50.

Supplemental Content

Loading ...
Support Center